Kimia Biosciences Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 364.843 million compared to INR 211.697 million a year ago. Net loss was INR 9.062 million compared to INR 7.914 million a year ago. Basic loss per share from continuing operations was INR 0.19 compared to INR 0.2 a year ago. Diluted loss per share from continuing operations was INR 0.19 compared to INR 0.17 a year ago. For the full year, total revenue was INR 1,351.7 million compared to INR 1,072.5 million a year ago. Net income was INR 51.044 million compared to INR 13.811 million a year ago. Basic earnings per share from continuing operations was INR 1.08 compared to INR 0.32 a year ago. Diluted earnings per share from continuing operations was INR 1.08 compared to INR 0.28 a year ago.